<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000468786"><TermName>post-transplant lymphoproliferative disorder</TermName><TermPronunciation>(post-TRANZ-plant LIM-foh-proh-LIH-feh-ruh-tiv dis-OR-der)</TermPronunciation><TermDefinition><DefinitionText>A condition in which a group of B-cells grow out of control after an organ transplant in patients with weakened immune systems. This usually happens if the patient has also been infected with Epstein-Barr virus. Post-transplant lymphoproliferative disorder may progress to non-Hodgkin lymphoma. Also called PTLD.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000716802" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;post-transplant lymphoproliferative disorder&quot;" language="en" id="_3"/><MediaLink ref="CDR0000716803" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;trastorno linfoproliferativo postrasplante&quot;" language="es" id="_4"/><SpanishTermName>trastorno linfoproliferativo postrasplante</SpanishTermName><SpanishTermDefinition><DefinitionText>Afección en la que un grupo de células B crece fuera de control después de un trasplante de órgano en pacientes con el sistema inmunitario debilitado. Por lo general, esto ocurre si el paciente también se ha infectado con el virus de Epstein-Barr. El trastorno linfoproliferativo postrasplante puede evolucionar y convertirse en un linfoma no Hodgkin. También se llama TLPT.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-10-14</DateFirstPublished><DateLastModified>2008-02-19</DateLastModified></GlossaryTerm>
